ALPMY
ASTELLAS PHARMA/ADR

308
Mkt Cap
$2.85T
Volume
70,392.00
52W High
$12.11
52W Low
$8.37
PE Ratio
32.59
ALPMY Fundamentals
Price
$10.95
Prev Close
$10.28
Open
$10.80
50D MA
$11.03
Beta
0.32
Avg. Volume
120,797.52
EPS (Annual)
$0.1859
P/B
1.79
Rev/Employee
$919,438.95
Loading...
Loading...
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13,643

Frequently Asked Questions

What is Market Cap of Astellas Pharma Inc. - ADR?
What is the 52-week high for Astellas Pharma Inc. - ADR?
What is the 52-week low for Astellas Pharma Inc. - ADR?
What is Astellas Pharma Inc. - ADR stock price today?
What was Astellas Pharma Inc. - ADR stock price yesterday?
What is the PE ratio of Astellas Pharma Inc. - ADR?
What is the Price-to-Book ratio of Astellas Pharma Inc. - ADR?
What is the 50-day moving average of Astellas Pharma Inc. - ADR?
How many employess does Astellas Pharma Inc. - ADR has?

Latest ALPMY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.